Five takeaways from The Inquirer’s investigation into CHOP’s innovative lymphatic program
The reporting found CHOP downplayed risks, including death and stroke, as procedural complications mounted.

The reporting found CHOP downplayed risks, including death and stroke, as procedural complications mounted.